第一作者机构：[1]Department of Endocrine and Breast Surgery, The first Affiliated Hospital of Chongqing Medical University, Chongqing, China
推荐引用方式(GB/T 7714)：
Li Y.,Xing L.,Yin X.,et al.A meta-analysis of the efficacy of adding immune checkpoint inhibitors to neoadjuvant chemotherapy against triple-negative breast cancer[J].ANNALS OF ONCOLOGY.2021,32:S50-S51.doi:10.1016/j.annonc.2021.03.082.
APA：
Li, Y.,Xing, L.,Yin, X.,Li, H.&Ren, G..(2021).A meta-analysis of the efficacy of adding immune checkpoint inhibitors to neoadjuvant chemotherapy against triple-negative breast cancer.ANNALS OF ONCOLOGY,32,
MLA：
Li, Y.,et al."A meta-analysis of the efficacy of adding immune checkpoint inhibitors to neoadjuvant chemotherapy against triple-negative breast cancer".ANNALS OF ONCOLOGY 32.(2021):S50-S51
医学